Concepedia

Mathilde Saint‐Ghislain

MS

3

Publications

59

Citations

3

H-Index

2017

Active since

Affiliations

Inserm(Current)

Université Paris Sciences et Lettres

La Ligue Contre le Cancer

Université Paris Cité

Institut Curie

Mathilde Saint‐Ghislain is an author at Inserm specializing in medicine, radiation oncology, and obstetrics.

ORCID

Top concepts

Publications per year

2017–2022

3

Publications

3

MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients

Mathilde Saint‐Ghislain, Anne‐Céline Derrien, Lionnel Geoffrois et al. · European Journal of Cancer · 2022 · 32 citations

, , +6

Influence of adjuvant chemotherapy on anti-Müllerian hormone in women below 35 years treated for early breast cancer

Anne Perdrix, Mathilde Saint‐Ghislain, Marie Degremont et al. · Reproductive BioMedicine Online · 2017 · 14 citations

, , +9

Nivolumab plus ipilimumab in metastatic uveal melanoma: a real-life, retrospective cohort of 47 patients

Hélène Salaün, Leanne de Koning, Mathilde Saint‐Ghislain et al. · OncoImmunology · 2022 · 13 citations · Full text

Rows per page

1–3 of 3